Donald Halbert has joined Iconix Pharmaceuticals as executive vice president of research and development, the company said last week.
Halbert joins Iconix from Abbott Laboratories, where he was director of genomics, proteomics, and bioinformatics in the global pharmaceutical research and development group. In addition, he was chairman of the Abbott-Iconix scientific advisory committee, overseeing the two companies’ 2003 alliance. Previously, he held scientific and management positions at Becton Dickinson. Halbert has a PhD in molecular virology from Washington University in St. Louis.
Steven Salzberg, senior director of bioinformatics at The Institute for Genomic Research, will be leaving his post this summer to serve as director of the center for bioinformatics and computational biology at the University of Maryland, according to BioInform, an Inside Bioassays sister publication.
Graham Fleming will be the new deputy director of Lawrence Berkeley National Laboratory, Berkeley Lab said last week. He will replace Pier Oddone, who will become director of the Fermi National Accelerator Laboratory in July. Fleming has been the lab’s physical biosciences division director. He holds a PhD in chemistry from the University of London.
Arcturus Bioscience has appointed Toni Schuh as CEO, the Mountain View, Calif.-based firm said this week. Schuh will also be elected to Arcturus’ board of directors, the company said.
Schuh joins Arcturus from Sequenom, where he served as CEO from May 2000 to February 2005. He has also served as managing director of Sequenom GmbH, the company’s initial operations in Germany, as well as its executive vice president of business development.
Arcturus also announced this week that Richard Kniss, an Arcturus board member since 2002, will be appointed non-executive chairman. Kniss was senior vice president and general manager of the life science and chemical group of Agilent Technologies prior to his retirement in 2001 after 34 years with Agilent and Hewlett Packard, Arcturus said.